Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
10 2019
Historique:
received: 17 02 2019
revised: 03 08 2019
accepted: 07 09 2019
pubmed: 18 10 2019
medline: 25 8 2020
entrez: 18 10 2019
Statut: ppublish

Résumé

The 2008 diagnostic criteria classify Multiple System Atrophy (MSA) patients in a predominantly parkinsonian (MSA-P) or cerebellar (MSA-C) type. Phenotypic descriptions have since highlighted a clinical heterogeneity among patients (e.g., mixed-type, cognitive impairment, atypical longer survival). This study attempts to identify different phenotypes of patients with MSA and to describe corresponding brain 18-FDG Positron Emission Tomography (PET) patterns. Patients with a "probable" MSA diagnosis for whom a brain 18-FDG PET was performed were included. A retrospective analysis (from 2006 to 2017) was conducted using standardized data collection. We used Latent Class Analysis (LCA), an innovative statistical approach, to identify profiles of patients based on common clinical characteristics. Brain metabolism of different groups was studied at rest. Eighty-five patients were included. Three different profiles were revealed (entropy = 0.835): 1. extrapyramidal, axial, laryngeal-pharyngeal involvement (LPI) and cerebellar symptoms (n = 46, 54.1%); 2. cerebellar and LPI symptoms (n = 30, 35.3%); 3. cerebellar and cognitive symptoms (n = 9, 10.6%). Brain metabolism analyses (k > 89; p < 0.001) showed hypometabolism of the basal ganglia, frontal/prefrontal, temporal cortices and left posterior cerebellum in profile 1. In profile 2 there was hypometabolism of the medulla, prefrontal, temporal, cingular cortices, putamen and bilateral cerebellar hemispheres. In profile 3 there was hypometabolism of bilateral posterior cerebellar hemispheres and vermis. Beyond the two most common phenotypes of MSA, a third and particularly atypical profile with cerebellar and cognitive symptoms but without LPI involvement is described. These profiles are supported by different brain metabolic abnormalities which could be useful for diagnostic purposes.

Identifiants

pubmed: 31621603
pii: S1353-8020(19)30382-7
doi: 10.1016/j.parkreldis.2019.09.005
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-9

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Stephan Grimaldi (S)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France. Electronic address: stephan.grimaldi@ap-hm.fr.

Mohamed Boucekine (M)

Aix-Marseille Univ, EA 3279 - Self-perceived Health Assessment Research Unit, 13005, Marseille, France.

Tatiana Witjas (T)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France; Aix Marseille Univ, CNRS, UMR 7289, Institut de Neurosciences de la Timone, 13385, Marseille, France.

Frédérique Fluchère (F)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France.

Mathilde Renaud (M)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France; Service de Génétique Clinique, CHU de Nancy, Hôpitaux de Brabois, 54500, Vandoeuvre, France.

Jean-Philippe Azulay (JP)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France.

Eric Guedj (E)

Aix-Marseille Univ, CNRS, Ecole Centrale Marseille, UMR, 7249, Institut Fresnel, Marseille, France; Aix-Marseille Univ, APHM, CHU Timone, Service Central de Biophysique et Médecine Nucléaire, 13385, Marseille Cedex 05, France; Aix-Marseille Univ, CERIMED, Bd Jean Moulin, 13005, Marseille, France.

Alexandre Eusebio (A)

Aix-Marseille Univ, APHM, CHU Timone, Department of Neurology and Movement Disorders, 13385, Marseille Cedex 05, France; Aix Marseille Univ, CNRS, UMR 7289, Institut de Neurosciences de la Timone, 13385, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH